An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Striverdi Respimat

Chemical Nameolodaterol
Dosage FormInhalation spray (oral; 2.5 mcg)
Drug ClassReceptor agonists
SystemRespiratory
CompanyBoehringer Ingelheim Pharmaceuticals
Approval Year2014

Indication

  • For the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Last updated on 4/20/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Striverdi Respimat (olodaterol) Prescribing Information 2014Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT
Document TitleYearSource
Comparisons of exacerbations and mortality among LAMA/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis.2020Respiratory Research
Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.2019The Cochrane Database of systematic reviews
Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials. 2019International Journal of Chronic Obstructive Pulmonary Disease
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review. 2018International Journal of COPD
Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.2017Respiratory Research
The impact of olodaterol on the risk of mortality and serious adverse events: a systematic review and meta-analysis.2016British Journal of Clinical Pharmacology
Document TitleYearSource
Romanian clinical guideline for diagnosis and treatment of COPD.2020Journal of International Medical Research